Jeyachitra Amirdhanayagam

Formulation and clinical translation of [¹⁷⁷Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancer

Mohini Guleria, Rohit Sharma, Jeyachitra Amirdhanayagam et al. · RSC Medicinal Chemistry · 2020 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of ⁶⁸ Ga-Labeled Porphyrin: Impact on Pharmacokinetics and Tumor Uptake in a Mouse Model

Mohini Guleria, Tapas Das, Jeyachitra Amirdhanayagam et al. · Cancer Biotherapy and Radiopharmaceuticals · 2018 · 20 citations

Medicine, Pharmacokinetics, Pharmacology +17

Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study

Mohini Guleria, Tapas Das, Chandan Kumar et al. · Anti-Cancer Agents in Medicinal Chemistry · 2017 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Preparation of clinical‐scale ¹⁷⁷<scp>L</scp>u‐<scp>R</scp>ituximab: <scp>O</scp>ptimization of protocols for conjugation, radiolabeling, and freeze‐dried kit formulation

Mohini Guleria, Tapas Das, Chandan Kumar et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2017 · 13 citations

Pharmacy, Nuclear Medicine, Pharmacokinetics +17

Effect of structural variation on tumor targeting efficacy of cationically charged porphyrin derivatives: Comparative in-vitro and in-vivo evaluation for possible potential in PET and PDT

Mohini Guleria, Shishu Kant Suman, Jyotsna Bhatt Mitra et al. · European Journal of Medicinal Chemistry · 2021 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +12